Trust Company of Vermont’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $4.6M | Sell |
184,643
-32,076
| -15% | -$809K | 0.19% | 97 |
|
|
2025
Q3 | $5.52M | Sell |
216,719
-29,372
| -12% | -$725K | 0.24% | 90 |
|
|
2025
Q2 | $5.97M | Sell |
246,091
-36,394
| -13% | -$849K | 0.28% | 82 |
|
|
2025
Q1 | $7.16M | Sell |
282,485
-41,031
| -13% | -$1.07M | 0.36% | 69 |
|
|
2024
Q4 | $8.58M | Sell |
323,516
-84,607
| -21% | -$2.29M | 0.42% | 64 |
|
|
2024
Q3 | $11.8M | Buy |
408,123
+6,243
| +2% | +$182K | 0.59% | 50 |
|
|
2024
Q2 | $11.2M | Buy |
401,880
+14,554
| +4% | +$401K | 0.61% | 47 |
|
|
2024
Q1 | $10.7M | Buy |
387,326
+67,617
| +21% | +$1.88M | 0.6% | 52 |
|
|
2023
Q4 | $9.2M | Sell |
319,709
-49,871
| -13% | -$1.51M | 0.61% | 54 |
|
|
2023
Q3 | $12.3M | Buy |
369,580
+29,546
| +9% | +$1.04M | 0.83% | 36 |
|
|
2023
Q2 | $12.5M | Buy |
340,034
+32,254
| +10% | +$1.26M | 0.81% | 34 |
|
|
2023
Q1 | $12.6M | Buy |
307,780
+13,841
| +5% | +$598K | 0.88% | 33 |
|
|
2022
Q4 | $15.1M | Buy |
293,939
+7,887
| +3% | +$378K | 1.1% | 24 |
|
|
2022
Q3 | $12.5M | Buy |
286,052
+2,589
| +0.9% | +$126K | 0.99% | 27 |
|
|
2022
Q2 | $14.9M | Sell |
283,463
-10,043
| -3% | -$512K | 1.14% | 22 |
|
|
2022
Q1 | $15.2M | Sell |
293,506
-12,263
| -4% | -$636K | 1.03% | 26 |
|
|
2021
Q4 | $18.1M | Buy |
305,769
+15,800
| +5% | +$783K | 1.14% | 20 |
|
|
2021
Q3 | $12.5M | Sell |
289,969
-4,716
| -2% | -$209K | 0.89% | 35 |
|
|
2021
Q2 | $11.5M | Buy |
294,685
+12,429
| +4% | +$483K | 0.8% | 38 |
|
|
2021
Q1 | $10.2M | Buy |
282,256
+10,557
| +4% | +$375K | 0.77% | 42 |
|
|
2020
Q4 | $10M | Buy |
271,699
+3,562
| +1% | +$131K | 0.8% | 39 |
|
|
2020
Q3 | $9.34M | Buy |
268,137
+14,108
| +6% | +$495K | 0.85% | 34 |
|
|
2020
Q2 | $7.88M | Sell |
254,029
-48,686
| -16% | -$1.65M | 0.78% | 39 |
|
|
2020
Q1 | $9.37M | Buy |
302,715
+13,358
| +5% | +$455K | 0.88% | 36 |
|
|
2019
Q4 | $10.8M | Buy |
289,357
+7,434
| +3% | +$265K | 0.81% | 43 |
|
|
2019
Q3 | $9.61M | Sell |
281,923
-6,184
| -2% | -$225K | 0.77% | 44 |
|
|
2019
Q2 | $11.8M | Buy |
288,107
+1,375
| +0.5% | +$54.6K | 0.98% | 33 |
|
|
2019
Q1 | $11.6M | Buy |
286,732
+851
| +0.3% | +$34.1K | 0.99% | 30 |
|
|
2018
Q4 | $11.8M | Sell |
285,881
-4,271
| -1% | -$177K | 1.14% | 21 |
|
|
2018
Q3 | $12.1M | Sell |
290,152
-7,809
| -3% | -$301K | 1.02% | 24 |
|
|
2018
Q2 | $10.3M | Buy |
297,961
+14,182
| +5% | +$485K | 0.92% | 31 |
|
|
2018
Q1 | $9.55M | Sell |
283,779
-1,936
| -0.7% | -$66.6K | 0.9% | 32 |
|
|
2017
Q4 | $9.82M | Buy |
285,715
+16,952
| +6% | +$578K | 0.91% | 33 |
|
|
2017
Q3 | $9.1M | Buy |
268,763
+2,313
| +0.9% | +$74.3K | 0.9% | 34 |
|
|
2017
Q2 | $8.49M | Buy |
266,450
+7,377
| +3% | +$233K | 0.87% | 32 |
|
|
2017
Q1 | $8.41M | Buy |
259,073
+2,406
| +0.9% | +$75.9K | 0.91% | 29 |
|
|
2016
Q4 | $7.91M | Buy |
256,667
+3,036
| +1% | +$92.7K | 0.91% | 28 |
|
|
2016
Q3 | $8.15M | Buy |
253,631
+15,384
| +6% | +$514K | 1.02% | 25 |
|
|
2016
Q2 | $7.96M | Buy |
238,247
+10,984
| +5% | +$351K | 1.06% | 24 |
|
|
2016
Q1 | $6.39M | Sell |
227,263
-308
| -0.1% | -$8.8K | 0.89% | 31 |
|
|
2015
Q4 | $6.97M | Buy |
227,571
+1,208
| +0.5% | +$38K | 1% | 27 |
|
|
2015
Q3 | $6.75M | Buy |
226,363
+2,789
| +1% | +$89.4K | 1.05% | 25 |
|
|
2015
Q2 | $7.11M | Buy |
223,574
+1,345
| +0.6% | +$43.8K | 1.03% | 26 |
|
|
2015
Q1 | $7.33M | Sell |
222,229
-4,244
| -2% | -$135K | 1.07% | 27 |
|
|
2014
Q4 | $6.69M | Buy |
226,473
+3,493
| +2% | +$100K | 0.98% | 32 |
|
|
2014
Q3 | $6.26M | Buy |
222,980
+16,309
| +8% | +$458K | 0.95% | 30 |
|
|
2014
Q2 | $5.82M | Buy |
206,671
+2,647
| +1% | +$75.5K | 0.9% | 35 |
|
|
2014
Q1 | $6.22M | Buy |
204,024
+9,051
| +5% | +$270K | 1.02% | 26 |
|
|
2013
Q4 | $5.67M | Sell |
194,973
-1,086
| -0.6% | -$31.6K | 0.95% | 28 |
|
|
2013
Q3 | $5.34M | Sell |
196,059
-38
| -0% | -$1.03K | 0.98% | 28 |
|
|
2013
Q2 | $5.21M | Buy |
+196,097
| New | +$5.42M | 1.02% | 26 |
|
Other funds holding PFE
Trust Company of Vermont's PFE Position: Q4 2025 in Review
Trust Company of Vermont reduced its Pfizer (PFE) stake by 15% in Q4 2025, selling an estimated $809K and leaving 184,643 shares worth $4.6M. The position accounts for 0.19% of the portfolio, ranked #97.
Trust Company of Vermont first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $18.1M in Q4 2021. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Trust Company of Vermont held 184,643 shares of Pfizer worth $4.6M as of Q4 2025.
- Trust Company of Vermont sold 32,076 Pfizer shares in Q4 2025, an estimated $809K.
- Pfizer made up 0.19% of Trust Company of Vermont's portfolio in Q4 2025, its #97 holding.
- Trust Company of Vermont first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- Trust Company of Vermont's Pfizer position peaked at $18.1M in Q4 2021.
- 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.